Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Seth P. Boudreaux"'
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150450 (2016)
Members of the NR4A subfamily of orphan nuclear receptors regulate cell fate decisions via both genomic and non-genomic mechanisms in a cell and tissue selective manner. NR4As play a key role in maintenance of hematopoietic stem cell homeostasis and
Externí odkaz:
https://doaj.org/article/f0d381b28ead481986458c3ffa7de2b3
Autor:
Dilip Depan, Siva Murru, Frank R. Fronczek, Richard S. Perkins, Victoria Meiklejohn, Radhey S. Srivastava, Seth P. Boudreaux
Publikováno v:
New Journal of Chemistry. 42:6858-6866
The reaction of mer-[RuCl3(S-TMSO)2(O-TMSO)] (TMSO = tetramethylene sulfoxide) with azoles (pyrazole = pzH and 3,5-dimethylpyrazole = dmpzH) in dichloromethane produced the complexes mer-[RuCl3(S-TMSO)(pzH)2] 1, mer-[RuCl3(S-TMSO)(O-TMSO)(pzH)] 2, me
Publikováno v:
The FASEB Journal. 33
While global average life expectancy has been consistently increasing in recent year, a gap between healthy life expectancy and the average life expectancy has not been filled yet. Sarcopenia, whic...
Autor:
Michele S. Redell, Steven G Call, Ryan P. Duren, Loc Nguyen, Pablo R. Freire, Seth P. Boudreaux, Orla M. Conneely, Padmini Narayanan
Publikováno v:
Leukemia
NR4As are AML tumor suppressors that are frequently silenced in human acute myeloid leukemia (AML). Despite their potential as novel targets for therapeutic intervention, mechanisms of NR4A silencing and strategies for their reactivation remain poorl
Publikováno v:
Psychoneuroendocrinology. 100:S14
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 3, p e0150450 (2016)
PLoS ONE, Vol 11, Iss 3, p e0150450 (2016)
Members of the NR4A subfamily of orphan nuclear receptors regulate cell fate decisions via both genomic and non-genomic mechanisms in a cell and tissue selective manner. NR4As play a key role in maintenance of hematopoietic stem cell homeostasis and
Publikováno v:
Oncogenesis
Acute myeloid leukemias (AMLs) are a heterogeneous group of diseases that are sustained by relatively rare leukemia-initiating cells (LICs) that exhibit diverse genetic and phenotypic properties. AML heterogeneity presents a major challenge to develo